Clinical Trials Sponsored by Ortotech

Total 54 results

Consorzio Oncotech

Active, not recruiting

Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients (GIM 23- POSTER)

Early Breast Cancer

Italy
Consorzio Oncotech

Unknown

Overcoming Endocrine Resistance in Metastatic Breast Cancer (OVER)

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Recruiting

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Metastatic Breast Cancer | Locally Advanced Breast Cancer

Italy
Consorzio Oncotech

Completed

Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study (ARIES)

Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer

Italy
Consorzio Oncotech

Active, not recruiting

Atezolizumab Plus CArboplatin Plus Nab-paclitaxel

Metastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene Mutation

Italy
Consorzio Oncotech

Active, not recruiting

Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Unknown

Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin (LUNG-NEPA)

Chemotherapy-induced Nausea and Vomiting

Italy
Consorzio Oncotech

Completed

NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer (GIM15-NEPA)

Chemotherapy-induced Nausea and Vomiting
Consorzio Oncotech

Unknown

Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments (BIO-META)

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Completed

FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC (GIM9)

Breast Cancer

Italy
Fondazione Oncotech

Not yet recruiting

NEOadjuvant Abemaciclib and GIredestrant triaL in Patients With ER-positive, HER2-negative Early Breast Cancer (Neo-AGILE)

Breast Cancer

Italy
Consorzio Oncotech

Recruiting

Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer (PE-PE)

Oligometastatic Renal Cell Carcinoma

Italy
Consorzio Oncotech

Completed

Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial) (GIM21)

Metastatic Breast Cancer

Italy
Consorzio Oncotech

Unknown

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Prostate Cancer | Castration-resistant Prostate Cancer

Italy
Consorzio Oncotech
Pfizer

Recruiting

Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients (AxIn)

Metastatic Renal Cell Carcinoma

Italy
Urgotech
ESPCI Paris

Completed

Validation of the EEG Signal Quality Measured by the URGOnight Device and Comparison With a Clinical Device (SIGMA)

Healthy Volonteers

France
Mitotech, SA
ORA, Inc.

Completed

Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome (VISTA-2)

Dry Eye Syndrome

United States
Mitotech, SA
ORA, Inc.

Completed

A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

Keratoconjunctivitis Sicca

United States
Spine Centre of Southern Denmark
CeraPedics, Inc; Ortotech

Completed

The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Fusion The IVANOS-study (IVANOS)

Low Back Pain | Spinal Stenosis

Denmark
Mitotech, SA
ORA, Inc.

Completed

Study of SkQ1 as Treatment for Dry-eye Syndrome (VISTA-1)

Dry Eye Syndrome

United States
KitoTech Medical, Inc.
Brown University

Unknown

Evaluation of microMend Device to Close Lacerations

Lacerations | Wounds

United States
Consorzio Oncotech
Roche Pharma AG

Recruiting

Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy

Breast Cancer

Italy
AdministrateurDRC
University Hospital, Grenoble; Urgotech

Terminated

Effectiveness and Acceptability of a Digital Solution to Train Specific EEG Frequencies With Neurofeedback for Improving Sleep (CONNECTOSOM)

Sleep Disorder | Insomnia

France
Oncotech

Unknown

Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

Breast Cancer

United States
Osteotech, Inc

Completed

Study Performance of The Plexur P™ Bone Void Filler Device in Patients Undergoing Iliac Crest Harvesting Procedures

Iliac Crest Harvesting Procedure-Bone Void Filler

United States
Dormotech Medical
Assaf-Harofeh Medical Center

Completed

Evaluation of the Usability and Performance Assessment of the DormoTech VLAB Device as a Home Sleep Test

Sleep Disorder

Israel
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients (GIM11-BERGI)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer (FEVEX)

Breast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant Neoplasm

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients (FUMANCE)

Metastatic Breast Cancer

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Recruiting

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma (TIDE-A)

Renal Carcinoma Metastatic

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies

Metastatic Breast Cancer

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Observation of Medical Treatments in MBC HER2-negative Patients (AMBRA)

Metastatic Breast Cancer

Italy
Ourotech, Inc.
Barts & The London NHS Trust

Recruiting

Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment (PEAR-TNBC)

Triple Negative Breast Cancer | Triple Negative Breast Neoplasms

United Kingdom
Ourotech, Inc.
Imperial College Healthcare NHS Trust

Recruiting

Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO) (PEAR-GLIO)

Glioblastoma | Brain Tumor | Ependymoma | Oligodendroglioma | Glioma, Malignant

United Kingdom
Children's Hospital of Orange County
KitoTech Medical, Inc.

Recruiting

Comparison of microMend® Devices to Sutures in Closing Lacerations in Children

Wound Heal | Laceration | Skin Wound

United States
Consorzio Oncotech
Quercegen Pharmaceuticals; Clinical Research Technology S.r.l.

Unknown

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial (QUASAR)

Kidney Cancer | Renal Cell Carcinoma

Italy
UnicoCell Biomed CO. LTD
Protech Pharmaservices Corporation (PPC)

Completed

Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease

Moderate to Severe Chronic Kidney Disease

Taiwan
Direction Centrale du Service de Santé des Armées
Urgotech

Recruiting

Implementation of a Post-traumatic Stress Disorder PREvention Program Within the French ARmy (PREPAR)

Post Traumatic Stress Disorder

France
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative Pain

Total Knee Arthroplasty

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

Study Evaluating Treatment of Forefoot Pain Related to Nerve Entrapment Using the Cryo-Touch III Device

Entrapment Neuropathy

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Withdrawn

Evaluate the Iovera° Device in Treating Pain Associated With Anterior Cruciate Ligament Reconstruction

ACL Reconstruction
Pacira CryoTech, Inc., a wholly owned subsidiary...

Withdrawn

Iovera° to Treat Pain Associated With ACL Reconstruction and Rehabilitation

Anterior Cruciate Ligament Reconstruction

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles

Forehead Wrinkles

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

Prospective Study Evaluating the Treatment of Hyperdynamic Forehead Wrinkles

Wrinkles

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device

Glabellar Frown Lines | Frown Lines

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device

Glabellar Frown Lines | Frown Lines

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines

Skin Aging | Facial Wrinkles

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

Cryo-Touch III Refinement Study Investigational Plan

Skin Aging | Facial Wrinkles

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Terminated

Study to Evaluate Iovera®° in Adult Patients Undergoing Total Knee Arthroplasty

Post-Operative Pain Management

United States
Pacira CryoTech, Inc., a wholly owned subsidiary...

Completed

Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation

Facial Rhytides

United States

3

Subscribe